At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
ECOR Electrocore LLC
Trading 10-20 10:11:00 EDT
7.81
+0.18
+2.36%
High7.81Low7.40Vol9.71K
Open7.52D1 Closing7.63Amplitude5.37%
Mkt Cap70.41MTradable Cap46.87MTotal Shares9.02M
T/O73.53KT/O Rate0.16%Tradable Shares6.00M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

electroCore Director Thomas J. Errico Acquires Common Shares Worth $49,081.50
Reuters  ·  09-22
electroCore Director Thomas J. Errico Acquires Common Shares Worth $49,081.50
H.C. Wainwright Keeps Their Buy Rating on Electrocore (ECOR)
TIPRANKS  ·  09-22
H.C. Wainwright Keeps Their Buy Rating on Electrocore (ECOR)
RBC Capital Remains a Buy on Ecora Royalties PLC (ECOR)
TIPRANKS  ·  09-18
RBC Capital Remains a Buy on Ecora Royalties PLC (ECOR)
electroCore to Join H.C. Wainwright Global Investment Conference Fireside Chat
Reuters  ·  09-10
electroCore to Join H.C. Wainwright Global Investment Conference Fireside Chat
electroCore, Inc. Appoints Joshua Lev and Mike Fox as Co-Chief Executive Officers
THOMSON REUTERS  ·  09-09
electroCore, Inc. Appoints Joshua Lev and Mike Fox as Co-Chief Executive Officers
electroCore: Joshua Lev Will Continue Performing His Current CFO Responsibilities
THOMSON REUTERS  ·  09-09
electroCore: Joshua Lev Will Continue Performing His Current CFO Responsibilities
electroCore CFO and Interim President Joshua S. Lev Sells Common Shares Worth $169,020
Reuters  ·  08-26
electroCore CFO and Interim President Joshua S. Lev Sells Common Shares Worth $169,020
electroCore Director Thomas J. Errico Acquires 5,000 Common Shares for $49,272
Reuters  ·  08-17
electroCore Director Thomas J. Errico Acquires 5,000 Common Shares for $49,272
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Korro Bio (KRRO), Electrocore (ECOR) and BioLife Solutions (BLFS)
TIPRANKS  ·  08-07
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Korro Bio (KRRO), Electrocore (ECOR) and BioLife Solutions (BLFS)
electroCore, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary
Reuters  ·  08-07
electroCore, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary
electroCore Q2 Revenue Jumps, but Slightly Misses Estimates
Reuters  ·  08-07
electroCore Q2 Revenue Jumps, but Slightly Misses Estimates
electroCore Q2 FY26 Net Loss Narrows 17% to $3.1 Million; Net Sales Rise 28% to $9.5 Million
Reuters  ·  08-07
electroCore Q2 FY26 Net Loss Narrows 17% to $3.1 Million; Net Sales Rise 28% to $9.5 Million
electroCore Q2 EPS $(0.33) Beats $(0.40) Estimate, Sales $9.450M Miss $9.491M Estimate
Benzinga Earnings  ·  08-07
electroCore Q2 EPS $(0.33) Beats $(0.40) Estimate, Sales $9.450M Miss $9.491M Estimate
electroCore Q2 Net Income USD -3.059 Million
Reuters  ·  08-07
electroCore Q2 Net Income USD -3.059 Million
electroCore, Inc. Expected to Post a Loss of 42 Cents a Share - Earnings Preview
Reuters  ·  08-05
electroCore, Inc. Expected to Post a Loss of 42 Cents a Share - Earnings Preview
electroCore could report ‘conservative’ guidance with Q2, says H.C. Wainwright
TIPRANKS  ·  08-05
electroCore could report ‘conservative’ guidance with Q2, says H.C. Wainwright
electroCore Management to Attend Needham Virtual MedTech Conference
Reuters  ·  08-03
electroCore Management to Attend Needham Virtual MedTech Conference
Ecora Royalties PLC (ECOR) Receives a Buy from Canaccord Genuity
TIPRANKS  ·  08-01
Ecora Royalties PLC (ECOR) Receives a Buy from Canaccord Genuity
electroCore to Report Q2 Financial Results, Host Investor Webinar
Reuters  ·  07-30
electroCore to Report Q2 Financial Results, Host Investor Webinar
Ecora Royalties PLC (ECOR) Gets a Buy from RBC Capital
TIPRANKS  ·  07-30
Ecora Royalties PLC (ECOR) Gets a Buy from RBC Capital

Introduction

Company Name.
Electrocore LLC
Affiliated Markets:
NASDAQ
Listing Date:
--
Main Business:
electroCore, Inc., a commercial stage bioelectronic medicine and wellness company, provides non-invasive vagus nerve stimulation technology platform in the United States, the United Kingdom, and internationally. The company is developing gammaCore, a prescription only handheld device intended for regular or intermittent use for the acute treatment of pain associated with migraine and episodic cluster headache, as well as for the treatment of hemicrania continua and paroxysmal hemicrania. It also develops Truvaga for the support of general health and wellbeing; and TAC-STIM for human performance. In addition, the company offers gammacore Sapphire, a portable, reusable, rechargeable, and reloadable prescription medical device for various primary headache conditions. electroCore, Inc. was incorporated in 2005 and is headquartered in Rockaway, New Jersey.
Issue price:
--